STRS Ohio’s Haemonetics HAE Stock Holding History

STRS Ohio’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$693K	Hold	12,300	–	–	﹤0.01%	852
2025 Q4	$986K	Buy	+12,300	New	+$826K	﹤0.01%	706
2025 Q3	–	Sell	-2,900	Closed	-$216K	–	2234
2025 Q2	$216K	Buy	2,900 +700	+32%	+$46.3K	﹤0.01%	1636
2025 Q1	$140K	Sell	2,200 -700	-24%	-$47.6K	﹤0.01%	1587
2024 Q4	$226K	Hold	2,900	–	–	﹤0.01%	1465
2024 Q3	$233K	Sell	2,900 -1,100	-28%	-$88.9K	﹤0.01%	1523
2024 Q2	$331K	Buy	4,000 +1,000	+33%	+$88K	﹤0.01%	1408
2024 Q1	$256K	Sell	3,000 -8,600	-74%	-$675K	﹤0.01%	1486
2023 Q4	$991K	Hold	11,600	–	–	﹤0.01%	912
2023 Q3	$1.04M	Sell	11,600 -4,800	-29%	-$429K	﹤0.01%	879
2023 Q2	$1.4M	Sell	16,400 -200	-1%	-$16.9K	0.01%	783
2023 Q1	$1.37M	Sell	16,600 -300	-2%	-$24.3K	0.01%	810
2022 Q4	$1.33M	Sell	16,900 -1,900	-10%	-$153K	0.01%	816
2022 Q3	$1.39M	Sell	18,800 -1,800	-9%	-$129K	0.01%	727
2022 Q2	$1.34M	Sell	20,600 -2,900	-12%	-$172K	0.01%	758
2022 Q1	$1.49M	Buy	23,500 +21,800	+1,282%	+$1.19M	0.01%	845
2021 Q4	$90K	Hold	1,700	–	–	﹤0.01%	1916
2021 Q3	$120K	Buy	1,700 +900	+113%	+$56.8K	﹤0.01%	1909
2021 Q2	$53K	Buy	+800	New	+$56.6K	﹤0.01%	2097
2020 Q3	–	Sell	-12,131	Closed	-$1.09M	–	2229
2020 Q2	$1.09M	Buy	12,131 +3,331	+38%	+$336K	﹤0.01%	849
2020 Q1	$877K	Hold	8,800	–	–	﹤0.01%	772
2019 Q4	$1.01M	Sell	8,800 -4,200	-32%	-$508K	﹤0.01%	910
2019 Q3	$1.64M	Hold	13,000	–	–	0.01%	688
2019 Q2	$1.56M	Sell	13,000 -6,000	-32%	-$590K	0.01%	694
2019 Q1	$1.66M	Hold	19,000	–	–	0.01%	685
2018 Q4	$1.9M	Sell	19,000 -400	-2%	-$42K	0.01%	637
2018 Q3	$2.22M	Sell	19,400 -3,600	-16%	-$373K	0.01%	635
2018 Q2	$2.06M	Sell	23,000 -700	-3%	-$59.1K	0.01%	648
2018 Q1	$1.73M	Sell	23,700 -2,000	-8%	-$137K	0.01%	662
2017 Q4	$1.49M	Sell	25,700 -3,300	-11%	-$174K	0.01%	690
2017 Q3	$1.3M	Sell	29,000 -300	-1%	-$12.5K	0.01%	747
2017 Q2	$1.16M	Buy	29,300 +300	+1%	+$12.3K	0.01%	757
2017 Q1	$1.18M	Sell	29,000 -1,200	-4%	-$46.9K	0.01%	763
2016 Q4	$1.21M	Sell	30,200 -1,000	-3%	-$37.7K	0.01%	756
2016 Q3	$1.13M	Sell	31,200 -4,100	-12%	-$141K	0.01%	765
2016 Q2	$1.02M	Buy	35,300 +3,200	+10%	+$96.7K	﹤0.01%	798
2016 Q1	$1.12M	Buy	32,100 +700	+2%	+$22.6K	0.01%	746
2015 Q4	$1.01M	Hold	31,400	–	–	﹤0.01%	802
2015 Q3	$1.01M	Hold	31,400	–	–	﹤0.01%	814
2015 Q2	$1.3M	Buy	31,400 +10,585	+51%	+$446K	0.01%	723
2015 Q1	$935K	Buy	20,815 +18,315	+733%	+$766K	﹤0.01%	822
2014 Q4	$94K	Buy	2,500 +1,000	+67%	+$36.6K	﹤0.01%	1550
2014 Q3	$52K	Buy	1,500 +1,100	+275%	+$39.3K	﹤0.01%	1639
2014 Q2	$14K	Buy	+400	New	+$13.4K	﹤0.01%	1668
2014 Q1	–	Sell	-4,900	Closed	-$187K	–	1724
2013 Q4	$206K	Sell	4,900 -600	-11%	-$24.7K	﹤0.01%	1452
2013 Q3	$219K	Sell	5,500 -19,545	-78%	-$820K	﹤0.01%	1465
2013 Q2	$1.04M	Buy	+25,045	New	+$1.01M	﹤0.01%	822

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

STRS Ohio's HAE Position: Q1 2026 in Review

STRS Ohio held its Haemonetics (HAE) position steady in Q1 2026 at 12,300 shares worth $693K. The position accounts for ﹤0.01% of the portfolio, ranked #852.

STRS Ohio first reported a position in HAE in Q2 2013 and has held it in 47 quarters since. The position peaked at $2.22M in Q3 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

STRS Ohio held 12,300 shares of Haemonetics worth $693K as of Q1 2026.
STRS Ohio left its Haemonetics share count unchanged in Q1 2026.
Haemonetics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #852 holding.
STRS Ohio first reported a position in Haemonetics in Q2 2013 and has held it in 47 quarters since.
STRS Ohio's Haemonetics position peaked at $2.22M in Q3 2018.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.